{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:03:07Z","timestamp":1789423387592,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012830","name":"Development and Reform Commission of Hunan Province","doi-asserted-by":"publisher","award":["No. [2021]212-22"],"award-info":[{"award-number":["No. [2021]212-22"]}],"id":[{"id":"10.13039\/100012830","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10528-024-10875-6","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:02:02Z","timestamp":1719871322000},"page":"3220-3239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["m6A-YTHDF1 Mediated Regulation of GRIN2D in Bladder Cancer Progression and Aerobic Glycolysis"],"prefix":"10.1007","volume":"63","author":[{"given":"Meixian","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangju","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunhua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,29]]},"reference":[{"key":"10875_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s12276-020-0407-z","volume":"52","author":"SH Boo","year":"2020","unstructured":"Boo SH, Kim YK (2020) The emerging role of RNA modifications in the regulation of mRNA stability. Exp Mol Med 52:400\u2013408. https:\/\/doi.org\/10.1038\/s12276-020-0407-z","journal-title":"Exp Mol Med"},{"key":"10875_CR2","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.omtn.2021.10.023","volume":"26","author":"Z Chen","year":"2021","unstructured":"Chen Z, Zhong X, Xia M, Zhong J (2021) The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases. Mol Ther Nucleic Acids 26:1270\u20131279. https:\/\/doi.org\/10.1016\/j.omtn.2021.10.023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10875_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110685","volume":"107","author":"Z Chen","year":"2023","unstructured":"Chen Z, Song Y, Li P, Gao W (2023a) GRIN2D knockdown suppresses the progression of lung adenocarcinoma by regulating the E2F signalling pathway. Cell Signal 107:110685. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110685","journal-title":"Cell Signal"},{"key":"10875_CR4","doi-asserted-by":"publisher","first-page":"1162607","DOI":"10.3389\/fimmu.2023.1162607","volume":"14","author":"L Chen","year":"2023","unstructured":"Chen L et al (2023b) N6-methyladenosine reader YTHDF family in biological processes: structures, roles, and mechanisms. Front Immunol 14:1162607. https:\/\/doi.org\/10.3389\/fimmu.2023.1162607","journal-title":"Front Immunol"},{"key":"10875_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrurol.2014.129","volume":"11","author":"W Choi","year":"2014","unstructured":"Choi W et al (2014) Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer. Nat Rev Urol 11:400\u2013410. https:\/\/doi.org\/10.1038\/nrurol.2014.129","journal-title":"Nat Rev Urol"},{"key":"10875_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.biopha.2014.03.012","volume":"68","author":"SI Deutsch","year":"2014","unstructured":"Deutsch SI, Tang AH, Burket JA, Benson AD (2014) NMDA receptors on the surface of cancer cells: target for chemotherapy? Biomed Pharmacother 68:493\u2013496. https:\/\/doi.org\/10.1016\/j.biopha.2014.03.012","journal-title":"Biomed Pharmacother"},{"key":"10875_CR7","doi-asserted-by":"publisher","first-page":"20440","DOI":"10.18632\/oncotarget.7812","volume":"7","author":"HJ Ferguson","year":"2016","unstructured":"Ferguson HJ et al (2016) Glutamate dependent NMDA receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer. Oncotarget 7:20440\u201320454. https:\/\/doi.org\/10.18632\/oncotarget.7812","journal-title":"Oncotarget"},{"key":"10875_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032540","author":"S Gallo","year":"2023","unstructured":"Gallo S, Vitacolonna A, Crepaldi T (2023) NMDA receptor and its emerging role in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032540","journal-title":"Int J Mol Sci"},{"key":"10875_CR9","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1016\/j.clgc.2019.01.009","volume":"17","author":"P Gild","year":"2019","unstructured":"Gild P et al (2019) Contemporary survival rates for muscle-invasive bladder cancer treated with definitive or non-definitive therapy. Clin Genitourin Cancer 17:e488\u2013e493. https:\/\/doi.org\/10.1016\/j.clgc.2019.01.009","journal-title":"Clin Genitourin Cancer"},{"key":"10875_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.700947","volume":"11","author":"R Hai","year":"2021","unstructured":"Hai R, He L, Shu G, Yin G (2021) Characterization of histone deacetylase mechanisms in cancer development. Front Oncol 11:700947. https:\/\/doi.org\/10.3389\/fonc.2021.700947","journal-title":"Front Oncol"},{"key":"10875_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13000-023-01295-y","volume":"18","author":"DS Helal","year":"2023","unstructured":"Helal DS, Darwish SA, Awad RA, Ali DA, El-Guindy DM (2023) Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival. Diagn Pathol 18:11. https:\/\/doi.org\/10.1186\/s13000-023-01295-y","journal-title":"Diagn Pathol"},{"key":"10875_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.607224","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu J et al (2021) YTHDF1 is a potential pan-cancer biomarker for prognosis and immunotherapy. Front Oncol 11:607224. https:\/\/doi.org\/10.3389\/fonc.2021.607224","journal-title":"Front Oncol"},{"key":"10875_CR13","doi-asserted-by":"publisher","first-page":"1549357","DOI":"10.1155\/2022\/1549357","volume":"2022","author":"Q Li","year":"2022","unstructured":"Li Q, Gu Z, Tan Q, Ren L, Chen S (2022) MicroRNA-129-1-3p represses the progression of triple-negative breast cancer by targeting the GRIN2D gene. Biomed Res Int 2022:1549357. https:\/\/doi.org\/10.1155\/2022\/1549357","journal-title":"Biomed Res Int"},{"key":"10875_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","volume":"14","author":"W Lin","year":"2023","unstructured":"Lin W et al (2023) Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation. Nat Commun 14:265. https:\/\/doi.org\/10.1038\/s41467-022-35710-7","journal-title":"Nat Commun"},{"key":"10875_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.835265","volume":"13","author":"XS Liu","year":"2022","unstructured":"Liu XS et al (2022) Comprehensive analysis of YTHDF1 immune infiltrates and ceRNA in human esophageal carcinoma. Front Genet 13:835265. https:\/\/doi.org\/10.3389\/fgene.2022.835265","journal-title":"Front Genet"},{"key":"10875_CR16","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.bbrc.2019.08.107","volume":"518","author":"C Ma","year":"2019","unstructured":"Ma C, Liao S, Zhu Z (2019) Crystal structure of human YTHDC2 YTH domain. Biochem Biophys Res Commun 518:678\u2013684. https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.107","journal-title":"Biochem Biophys Res Commun"},{"key":"10875_CR17","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1016\/j.csbj.2023.06.018","volume":"21","author":"LG Miller","year":"2023","unstructured":"Miller LG, Demny M, Tamamis P, Contreras LM (2023) Characterization of epitranscriptome reader proteins experimentally and in silico: current knowledge and future perspectives beyond the YTH domain. Comput Struct Biotechnol J 21:3541\u20133556. https:\/\/doi.org\/10.1016\/j.csbj.2023.06.018","journal-title":"Comput Struct Biotechnol J"},{"key":"10875_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16091502","author":"KTH Pham","year":"2019","unstructured":"Pham KTH et al (2019) Health inequality between migrant and non-migrant workers in an industrial zone of Vietnam. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph16091502","journal-title":"Int J Environ Res Public Health"},{"key":"10875_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40364-023-00452-1","volume":"11","author":"W Ren","year":"2023","unstructured":"Ren W et al (2023) The function and clinical implication of YTHDF1 in the human system development and cancer. Biomark Res 11:5. https:\/\/doi.org\/10.1186\/s40364-023-00452-1","journal-title":"Biomark Res"},{"key":"10875_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12334","volume":"12","author":"JA S\u00e1nchez L\u00e1zaro","year":"2020","unstructured":"S\u00e1nchez L\u00e1zaro JA, Fern\u00e1ndez Hern\u00e1ndez \u00d3, Madera Gonz\u00e1lez F (2020) Arthroscopic contribution of synthetic graft in tibiotalocalcaneal arthroscopic fusions. Cureus 12:e12334. https:\/\/doi.org\/10.7759\/cureus.12334","journal-title":"Cureus"},{"key":"10875_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-021-01871-4","volume":"40","author":"X Wang","year":"2021","unstructured":"Wang X et al (2021) RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. J Exp Clin Cancer Res 40:80. https:\/\/doi.org\/10.1186\/s13046-021-01871-4","journal-title":"J Exp Clin Cancer Res"},{"key":"10875_CR22","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/j.gastro.2021.12.269","volume":"162","author":"S Wang","year":"2022","unstructured":"Wang S et al (2022) N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer. Gastroenterology 162:1183\u20131196. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.269","journal-title":"Gastroenterology"},{"key":"10875_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40364-023-00514-4","volume":"11","author":"J Wang","year":"2023","unstructured":"Wang J et al (2023) Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma. Biomark Res 11:74. https:\/\/doi.org\/10.1186\/s40364-023-00514-4","journal-title":"Biomark Res"},{"key":"10875_CR24","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J et al (2022) Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell 82:1660\u20131677. https:\/\/doi.org\/10.1016\/j.molcel.2022.02.033","journal-title":"Mol Cell"},{"key":"10875_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.629560","volume":"11","author":"Y Xu","year":"2021","unstructured":"Xu Y et al (2021) YTH domain proteins: a family of m(6)A readers in cancer progression. Front Oncol 11:629560. https:\/\/doi.org\/10.3389\/fonc.2021.629560","journal-title":"Front Oncol"},{"key":"10875_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202204910","volume":"35","author":"Q You","year":"2023","unstructured":"You Q et al (2023) m(6) A reader YTHDF1-targeting engineered small extracellular vesicles for gastric cancer therapy via epigenetic and immune regulation. Adv Mater 35:e2204910. https:\/\/doi.org\/10.1002\/adma.202204910","journal-title":"Adv Mater"},{"key":"10875_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.753051","volume":"11","author":"E Zboril","year":"2021","unstructured":"Zboril E, Yoo H, Chen L, Liu Z (2021) Dynamic interactions of transcription factors and enhancer reprogramming in cancer progression. Front Oncol 11:753051. https:\/\/doi.org\/10.3389\/fonc.2021.753051","journal-title":"Front Oncol"},{"key":"10875_CR28","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.3748\/wjg.v26.i41.6361","volume":"26","author":"X Zhang","year":"2020","unstructured":"Zhang X et al (2020) P-selectin glycoprotein ligand 1 deficiency prevents development of acute pancreatitis by attenuating leukocyte infiltration. World J Gastroenterol 26:6361\u20136377. https:\/\/doi.org\/10.3748\/wjg.v26.i41.6361","journal-title":"World J Gastroenterol"},{"key":"10875_CR29","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1089\/cbr.2021.0226","volume":"37","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Mei Y, Hou M (2022a) Knockdown RBM15 inhibits colorectal cancer cell proliferation and metastasis via N6-methyladenosine (m6A) modification of MyD88 mRNA. Cancer Biother Radiopharm 37:976\u2013986. https:\/\/doi.org\/10.1089\/cbr.2021.0226","journal-title":"Cancer Biother Radiopharm"},{"key":"10875_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.877657","volume":"12","author":"YG Zhang","year":"2022","unstructured":"Zhang YG, Jin MZ, Zhu XR, Jin WL (2022b) Reclassification of hepatocellular cancer with neural-related genes. Front Oncol 12:877657. https:\/\/doi.org\/10.3389\/fonc.2022.877657","journal-title":"Front Oncol"},{"key":"10875_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.842833","volume":"9","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Ju Q, Ji J, Li Y, Zhao Y (2022) N6-methyladenosine methylation regulator RBM15 is a potential prognostic biomarker and promotes cell proliferation in pancreatic adenocarcinoma. Front Mol Biosci 9:842833. https:\/\/doi.org\/10.3389\/fmolb.2022.842833","journal-title":"Front Mol Biosci"},{"key":"10875_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41420-023-01582-z","volume":"9","author":"J Zhong","year":"2023","unstructured":"Zhong J et al (2023) Circ_0000235 targets MCT4 to promote glycolysis and progression of bladder cancer by sponging miR-330-5p. Cell Death Discov 9:283. https:\/\/doi.org\/10.1038\/s41420-023-01582-z","journal-title":"Cell Death Discov"},{"key":"10875_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086905","author":"J Zhu","year":"2023","unstructured":"Zhu J et al (2023a) YTHDF1 promotes bladder cancer cell proliferation via the METTL3\/YTHDF1-RPN2-PI3K\/AKT\/mTOR Axis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24086905","journal-title":"Int J Mol Sci"},{"key":"10875_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41420-023-01321-4","volume":"9","author":"Y Zhu","year":"2023","unstructured":"Zhu Y et al (2023b) The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer. Cell Death Discov 9:34. https:\/\/doi.org\/10.1038\/s41420-023-01321-4","journal-title":"Cell Death Discov"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10875-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10875-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10875-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T03:44:59Z","timestamp":1752723899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10875-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10875"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10875-6","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,29]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}